Home › Bronchiolitis Obliterans Syndrome › Illinois › Chicago
Bronchiolitis Obliterans Syndrome clinical trials in Chicago, IL
5 studies for Bronchiolitis Obliterans Syndrome are looking for participants at sites in and around Chicago (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
RecruitingPhase 3
- Northwestern Memorial Hospital, Chicago
- University of Illinois, Chicago
Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
RecruitingObservational study
- Northwestern University, Chicago
- Rush University Medical Group, Chicago
- The University of Chicago, Chicago
Axatilimab in Combination With Extracorporeal Photopheresis (ECP) in Chronic Graft-versus-Host Disease
RecruitingPhase 2
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
RecruitingPhase 2
- The University of Chicago Medical Center (UCMC), Chicago
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
RecruitingPhase 2
- University of Illinois Medical Center - Hematology & Oncology, Chicago
Bronchiolitis Obliterans Syndrome trials in other cities
- Boston, MA13 studies
- Seattle, WA11 studies
- Atlanta, GA10 studies
- New York City, NY9 studies
- Houston, TX8 studies
- Los Angeles, CA7 studies
- Miami, FL7 studies
- Tampa, FL6 studies
- Durham, NC6 studies
- Baldwin Park, CA6 studies
- Washington, DC6 studies
- Philadelphia, PA6 studies
Other studies in Chicago
- Non-Small Cell Lung Cancer61 studies
- Breast Cancer58 studies
- Cancer (all types)51 studies
- Metastatic Cancer45 studies
- Prostate Cancer45 studies
- Obesity41 studies
- Lung Cancer41 studies
- Ovarian Cancer36 studies
- Stroke34 studies
- Colorectal Cancer33 studies
- Heart Failure31 studies
- Overweight28 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.